PD-1/PD-L1-based cancer immunotherapy has, thus, resulted in remarkable clinical success for treating advanced cancers, such as melanoma [2], non-small cell lung cancer [3,4], bladder cancer [5] and others [4,6]. The gene discussed is CD274; the disease is cancer.